2022 Multidisciplinary Head and Neck Cancers Symposium onDemand

The 2022 Multidisciplinary Head and Neck Cancers Symposium features interactive and case-based educational sessions that cover new multidisciplinary therapies, imaging, immunotherapy, treatment guidelines, supportive care and under disparities in head and neck cancer. A major focus is placed on the multidisciplinary nature of disease management and the incorporation of all treatment modalities to achieve best outcomes. Oral abstract and poster sessions will highlight cutting-edge science and evidence-based practice. Registrants will be able to examine multidisciplinary approaches for treating head and neck cancer, as well as novel therapies that show promise in improving outcomes.

Target Audience

This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.

Learning Objectives

Upon completion of this activity, registrants should be able to do the following:

  • Explain the importance of multidisciplinary care in head and neck cancer (HNC) and how to best apply it for optimal outcomes.
  • Describe key advances in systemic therapy, including targeted therapy and immunotherapy in HNC.
  • Discuss recent advances in minimally invasive surgery in HNC and when to apply it in treating early and locally advanced disease.
  • Illustrate how we can improve disparities in head and neck cancer care.
  • Determine the importance of interventions in survivorship clinics for long term side effects.
  • Describe key advances in radiation therapy delivery, targeting and differences between various modalities, including novel treatment approaches such as proton and FLASH radiotherapy.
  • Discuss complex cases in HNC and how to best utilize current knowledge for decision-making.
  • Manage toxicities related to the management of head and neck cancer.
  • Summarize key recent advances in HNC biology.
  • Summarize key recent advances in HNC imaging.
  • Discuss and implement standard treatment guidelines for various subtypes of HNCs.
Course summary
Available credit: 
  • 17.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 17.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 17.00 Certificate of Attendance
    This activity was designated for 17.00 AMA PRA Category 1 Credit™.
Course opens: 
03/04/2022
Course expires: 
02/26/2025
Cost:
$275.00
Rating: 
0

PROGRAM INSTRUCTIONS:

Registration:

Click on the Register tab in the course navigation. Scroll down to add the On Demand Course to your cart. All sessions listed are included with your purchase.

Navigation:

To begin:

  1.     Click on the Take Course tab in the course navigation to see the list of included sessions.
  2.     Click on the title of the session you would like to view.
  3.     Once in the session, review the overview, objectives, and faculty details before clicking Take Course to begin viewing the content.
  4.     Use the left Course Progress bar to navigate the session or the green buttons in the course navigation bar at the bottom.
  5.     You may view the sessions in any order and as many or as few as you wish to receive credit(s).

Once you have completed each session, you can return to the list of sessions available by clicking on Return to 2022 Multidisciplinary Head and Neck Cancers Symposium onDemand as seen in the example below.

Repeat the above steps to complete as many sessions as you wish to view. You may return later to complete or review any of the sessions.

To re-enter the On Demand course, you will find your 2022 Multidisciplinary Head and Neck Cancers Symposium onDemand in your Completed Activities tab even if you have sessions that have not been viewed available.

Go to the Take Course tab to re-access. Sessions that have been viewed/completed will have a checked circle and unviewed sessions will say Enrolled. You can view sessions as many times as you would like.

Certificates/Credits

You may view and claim credit for some or all of the virtual sessions. Each time you complete the viewing and evaluation of a session, your CME certificate for the course will update with the new credit hours awarded.

Name

Employment

Compensation/Renumeration/Funding

Ownership/Investment Interests

Leadership Positions

Julie BaumanUniversity of Arizona: Professor of Medicine: EmployeeNoneNoneNone
Liza BlumenfeldUC San Diego, Moores Cancer Center: Professor: EmployeeNoneNoneNone
Margaret Brandwein-WeberMount Sinai School of Medicine: Professor and Chief of PathologyNoneNoneNone
David BurkettThe Burkett Law Firm: Owner, President and Lead attorneyNoneAbbvie: Stock
Eli Lilly: Stock
None
Elizabeth CashUniversity of Louisville: EmployeeNoneNoneNone
Anne ChangStanford University: EmployeeMerck: clinical investigator and advisory panel  Regeneron: clinical investigator and advisory board: NoneNone
Bhisham CheraUniversity of North Carolina Hospitals: Associate Professor: EmployeeRO-HAC: ConsultantNaveris: Patent/License Fees/Copyright: StockACR: Editor
Head and Neck: Senior Editor
Naveris: Scientific Advisory Board: Scientific Advisory Board
Practical Radiation Oncology: Senior Editor: Senior Editor
Christine ChungMoffitt Cancer Center: Senior Member: EmployeeExelixis: Honoraria
Merck: Honoraria
Sanofi: Honoraria
NoneNone
Alexander  Dimitrios ColevasStanford university: Professor: EmployeeAbbvie: Research Grants
AdPNP: Research Grants
Aravive: Advisory Board  ATARA Biotherapeutics: Research Grants
BeiGene, Ltd: Consultant
BioNTech: Research Grants
Clarion: Interview
Clearview HCP (Clearview Oncology): Expert Interview  CUE Biopharma: Research Grants
Cue Biopharma, Inc.: Research Grants Cullinan: Research Grants
ECTCN: Research Grants
Exelixis: Research Grants
Forty Seven, Inc./Gilead: Research Grants Gilead: Advisory Board
Gilead: Research Grants
Innate Pharma: Research Grants
NCI: Research Grants
NRG Oncology: Research Grants
Replimune: Research Grants
Tessa Therapeutics: Research Grants
NoneAssn n cal oncologists: Board member
Nccn: Panel member: Formulate guidelines
Jonas de SouzaHCA Healthcare: VP Strategy: Employee Humana Inc: Director, Strategy: Employee: Relationship ended 06/11/2021NoneHCA Healthcare: Stock Options
Humana Inc: Stock
Patient Access Network: Board of Directors: Director
Neal DunlapUniversity of Louisville/James Graham Brown Cancer Center: EmployeeNoneNoneNone
Umamaheswar DuvvuriUniversity of Pittsburgh, School of Medicine: Professor: EmployeeActiv Surgical: ConsultantNoneActiv Surgical: Advisory Board: Consultant
Joel EpsteinCedars Sinai: Consulting dentist: Independent Contractor
City of Hope: Consulting dentist: Independent Contractor
Cedars Sinai: Consultant
City of Hope: Research Grants
NoneMultinational Assocfor Supportive Care in Cancer: Member: Board Member: Relationship ended 12/31/2019
Renata FerrarottoMD Anderson Cancer Center: Associate Professor: EmployeeAyala Pharmaceutical: Advisory Board: Research Grants
EMD Serono: Research Grants
Merck: Advisory Board
Nanobiotix: Research Grants
Pfizer: Research Grants
Regeneron-Sanofi: Advisory Board
NoneNone
Robert FerrisUPMC Hillman Cancer Center: Employee
University of Pittsburgh School of Medicine: Director
Achilles Therapeutics: Advisory Board
Aduro Biotech, Inc: Consultant
Astra-Zeneca/MedImmune: Research Funding & Clinical Trial
Bicara Therapeutics, Inc: Consultant
Bristol-Myers Squibb: Advisory Board: Clinical Trial & Research Funding
Brooklyn Immunotherapeutics LLC: Consultant
Everest Clinical Research Corporation: Consultant
F. Hoffmann-La Roche Ltd: Consultant Genocea Biosciences, Inc: Consultant
Hookipa Biotech GmbH: Advisory Board
Instil Bio, Inc: Advisory Board
Kowa Research Institute, Inc: Consultant Lifescience Dynamics Limited: Advisory Board
MacroGenics, Inc.: Advisory Board
Merck: Advisory Board: Clinical Trial
Mirati Therapeutics, Inc: Consultant
Nanobiotix: Consultant
Novasenta: Consultant: Research Grants Numab Therapeutics AG: Advisory Board OncoCyte Corporation: Advisory Board
Pfizer: Advisory Board
PPD Development, L.P.: Consultant
Rakuten Medical, Inc: Advisory Board
Sanofi: Consultant
Seagen, Inc: Advisory Board
Tesaro: Research Grants
Vir Biotechnology, Inc: Advisory Board Zymeworks, Inc.: Consultant
Novasenta: StockNone
Jessica GeigerDepartment of Hematology/Oncology, Taussig Cancer Institute, Cleveland ClinicNoneNoneNone
Maura GillisonUT MD Anderson Cancer Center: Professor: EmployeeBayer Healthcare: Consultant
Bicara Therapeutics: Consultant
BioNTech AG: Research Grants
Bristol-Myers Squibb: Consultant: Research Grants
Cullinan: Research Grants
Debiopharm: Consultant
Eisai Inc.: Consultant
EMD Serono: Consultant
Genenetch: Research Grants
Genocea Bioscience: Research Grants Gilead: Research Grants
Ipsen Biopharmaceuticals Inc.: Consultant Istari Oncology Inc.: Consultant
Kura Oncology Inc.: Research Grants
LLX Solutions, LLC: Consultant
Merck & Co. Inc.: Consultant
Nektar: Consultant
Roche Laboratories, Inc.: Consultant
Seagen: Consultant
Sensei Biotherapeutics Inc.: Consultant Shattucks Lab Inc.: Consultant
NoneMemorial Slan Kettering Cancer Center: Consultant: Committee Member
Neil HayesThe University of Tennessee Health Science Center: EmployeeMerck: Advisory BoardGeneCentric Therapeutics: Founder, license fees, consultantNone
Zain HusainSunnybrook Health Sciences Centre: Physician/Associate Professor: Staff PhysicianNoneNoneNIH Head and neck PULA task force: Member
Katherine HutchesonUniversity of Houston: Adjunct Professor: Employee
University of Texas MD Anderson Cancer Center: Professor: Employee
Atos Medical: In-kind Donations: Research Grants
MD Anderson Institutional Research Grant Program: Research Grants
National Institutes of Health: Research Grants
Patient Centered Outcomes Research Institute: Research Grants
THRIVE/HESI Foundation: Research Grants
NoneHead and Neck Cancer Alliance: Board Member
Jonathan IrishDepartment of Otolaryngology - Head & Neck Surgery, University Health Network, University of Toronto: Professor
Ontario Health-Cancer Care Ontario: Vice President of Clinical for Cancer Programs
NoneNoneNone
Faye JohnsonDepartment of Thoracic Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center: ProfessorTakeda: Research Grants
Trovagene: Research Grants
NoneNone
Kiran KakaralaDepartment of Otolaryngology, University of Kansas Medical Center: Associate ProfessorNoneNoneAmerican Head and Neck Society: Co-Chair: Co-Chair of Quality Committee
American Head and Neck Society: Vice-Chair: Vice Chair of Salivary Section
Sana KaramUniversity of Colorado, Anschutz Medical Campus: Associate Professor and Vice Chair of Translational Research: EmployeeAstraZeneca: Research Grants
Genentech: Research Grants
Roche: Research Grants
NoneNone
Saad KhanUT Southwestern: EmployeeNoneNoneNone
Shlomo KoyfmanCleveland Clinic: Associate Professor of Medicine: EmployeeBristolMyersSquibb: Research Grants
Castle Biosciences: Advisory board (unpaid) Merck: Advisory Board: Research Grants Regeneron: Advisory Board
UpToDate: Honoraria
NoneNone
Stephen LaiDepartment of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center: EmployeeCardinal Health: ConsultantNoneNone
Quynh-Thu LeStanford: Professor: EmployeeCoherus: Consultant
Merck: Travel Expenses
Nanobiotix: Consultant
NIH: Research Grants
Pfizer: Consultant
Roche: Consultant
Aldea: StockAmerican Radium Society: President elect: Relationship ended
Head and Neck Cancer International Group (HNCIG): Chair
RTOG NRG Cooperative group: Head and Neck Committee Chair: Chair of head and neck committee- design clinical trial
Nancy LeeMemorial Sloan-Kettering Cancer Center: Vice Chairman: EmployeeAstra Zeneca: Research Grants
Elsie: Advisory Board
Merck: Advisory Board: Research Grants Merck Serono: Advisory Board
Pfizer: Advisory Board: Research Grants; Roche: Advisory Board
NoneNone
Kelly MalloyUniversity of Michigan: Associate Professor: EmployeeUp To Date: Royalty for authored contentNoneNone
Susan McCammonUniversity of Alabama at Birmingham: ProfessorNoneNoneNone
Loren MellUCSD: Professor: EmployeeAstra-Zeneca: Research Grants
Merck: Research Grants
NoneNone
Charles MooreIndiana University: Professor, Vice Chair of Academic Affairs and Medical Director of the Health Joe and Shelly Schwartz Cancer CenterNoneNoneNone
Michael MooreIU HEALTH: Medical Director
Schwartz Cancer Center: Employee
Cancer support community: Advisory Board Gazak and Brown: Honoraria
Intuitive Surgical Inc: Travel Expenses PK Law: Honoraria
Rakuten medical: Advisory Board
NoneHEAD AND NECK CANCER ALLIANCE: PRESIDENT OF THE BOARD: I Oversee the Board and help guide the strategic plan for the organization.
Cherie-Ann NathanLSU Health: Professor and Chair: EmployeeNoneNoneNone
Marci NilsenSchool of Nusring and School of Medicine, University of Pittsburgh: Assistant ProfessorNoneNoneNone
Devin OkayMount Sinai Hospital: EmployeeNoneNoneNone
Urjeet PatelNorthwestern Memorial Hospital: Attending PhysicianNoneNoneNone
Andy  Pluemer NoneNoneNone
Eben RosenthalDepartment of Otolaryngology—Head and Neck Surgery, Vanderbilt University Medical Center: Guy Maness Profesor and ChairNIH: Research Grants
Vergent: Consultant
NoneNone
Gloria RubioUC San Diego, Moores Cancer Center: EmployeeNoneNoneNone
Nabil SabaDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University: EmployeeNoneNoneNone
Assuntina SaccoUniversity of California, San Diego Health: Associate Professor of Internal Medicine: EmployeeBicara Therapeutics: Advisory Board FirstThought: Consultant
Merck: Research Grants
Verimed: Consultant
NoneAmerican Radium Society: Head and Neck Appropriateness Use Criteria Committee: Expert: Relationship ended 07/01/2021
NCI PULA Task Force: NCI PULA Task Force: Special Expert
Cecelia SchmalbachTemple Health: EmployeeNoneNoneNone
Farzan SiddiquiHenry Ford Health System: Senior Staff Physician: EmployeeAmerican College of Radiology: Honoraria Varian Medial Systems Inc: Honoraria: Speaker's Bureau: Travel Expenses: Research Grants: Travel Expenses
Varian Noona: Advisory Board
NoneAmerican Radium Society: Member; Department of Radiation Oncology,
Henry Ford Hosp: Vice-Chairman Operations: Serve as liaison between Health System leadership and department
Henry Ford Medical Group Board of Governors: Member
HFHS Bylaws and Governance Committee: Committee Chair
Jennifer Sipos
Arthur G. James Comprehensive Cancer Center: Physician
Ohio State University: Physician
NoneNoneNone
Heath SkinnerMD Anderson Cancer Center: Assistant Professor: Employee: Relationship ended 08/31/2018
MD Anderson Cancer Center: Associate Professor: Employee: Relationship ended 09/10/2018
UPMC Hillman Cancer Center: Associate Professor: Employee
NIDCR: Research Grants
NIH: Research Grants
NoneNone
Sharon SpencerUniversity of Alabama at Birmingham: Radiation oncologistNoneNoneNone
Maie St. JohnUCLA Geffen School of Medicine: Professor and Chair
Head and Neck Surgery: Employee
NoneNoneNone
Heather StarmerStanford University: Clinical Associate Professor: EmployeeNoneNoneAm Board of Swallowing and Swallowing disorders: Board member: Co-chair of continuing education committee
American Head and Neck Society: Co-chair: service co-chair for head and neck cancer survivorship
American Speech Language Hearing Association: Topic chair: Topic chair for annual convention
Dysphagia Research Society: board member: Service on committee for membership
Paul SwiecickiDepartment of Internal Medicine, Division of Medical Oncology, University of Michigan: Assistant Professor of Hematology/Oncology, Co-Director of Multitumor Experimental Therapeutics/Phase 1 ProgramNoneNoneNone
Ravindra UppaluriDepartment of Surgery/Otolaryngology, Brigham & Women's Hospital: Division Cheif Head and Neck Surgery, Dana-Farber Cancer Institute: DirectorMerck Inc: Advisory BoardNoneNone
MarkVarvaresMassachusetts General Hospital: EmployeeNoneNoneNone
 Head and Neck Cancer Alliance: Patient AdvocateNoneNoneNone
Sue YomUniversity of California: EmployeeASTRO: Honoraria
BioMimetix: Research Grants
Bristol-Myers Squibb: Research Grants Elsevier: Honoraria
Genentech: Research Grants
Merck: Research Grants
Springer: Book chapter royalty
UpToDate: Book chapter royalty
NoneAmerican Society for Radiation Oncology: Deputy Editor
NRG Oncology: Chair
Mark ZafereoHead and Neck Surgery, The University of Texas MD Anderson Cancer Center: ProfessorEli Lilly: Research Grants;
Merck: Research Grants
NoneAmerican Academcy of Otololaryngology-Head & Neck Surgery: Board of Directors; International Thyroid Oncology Group: Board of Directors
Dan ZandbergUPMC Hillman Cancer Center, University of Pittsburgh: EmployeeNoneNoneNone

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 17.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 17.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 17.00 Certificate of Attendance
    This activity was designated for 17.00 AMA PRA Category 1 Credit™.
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$275.00
Please login or register to take this course.

Course Fees:
$275 for all member types.

Policies:
No refunds, extensions, or substitutions will be made for those registrants. Including those who for any reason,  have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.”

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.